Max Delbrück Center for Molecular Medicine (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany.
Gene Regulation of Cell Identity, Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.
Molecules. 2021 Aug 24;26(17):5113. doi: 10.3390/molecules26175113.
Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder that heavily burdens healthcare systems worldwide. There is a significant requirement to understand the still unknown molecular mechanisms underlying AD. Current evidence shows that two of the major features of AD are transcriptome dysregulation and altered function of RNA binding proteins (RBPs), both of which lead to changes in the expression of different RNA species, including microRNAs (miRNAs), circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and messenger RNAs (mRNAs). In this review, we will conduct a comprehensive overview of how RNA dynamics are altered in AD and how this leads to the differential expression of both short and long RNA species. We will describe how RBP expression and function are altered in AD and how this impacts the expression of different RNA species. Furthermore, we will also show how changes in the abundance of specific RNA species are linked to the pathology of AD.
阿尔茨海默病(AD)是最常见的与年龄相关的神经退行性疾病,给全球的医疗系统带来了沉重负担。因此,深入了解 AD 背后尚未阐明的分子机制至关重要。目前的证据表明,AD 的两个主要特征是转录组失调和 RNA 结合蛋白(RBPs)功能改变,这两者均导致不同 RNA 物种(包括 microRNAs(miRNAs)、环状 RNAs(circRNAs)、长非编码 RNA(lncRNAs)和信使 RNA(mRNAs))的表达发生变化。在这篇综述中,我们将全面概述 AD 中 RNA 动态如何发生改变,以及这如何导致短链和长链 RNA 物种的差异表达。我们将描述 AD 中 RBPs 的表达和功能如何发生改变,以及这如何影响不同 RNA 物种的表达。此外,我们还将展示特定 RNA 物种丰度的变化如何与 AD 的病理学相关联。